Girard Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $344K | Sell |
4,372
-401
| -8% | -$32.9K | 0.03% | 212 |
|
|
2024
Q1 | $416K | Sell |
4,773
-347
| -7% | -$29.6K | 0.04% | 202 |
|
|
2023
Q4 | $422K | Sell |
5,120
-4,279
| -46% | -$326K | 0.04% | 195 |
|
|
2023
Q3 | $737K | Sell |
9,399
-11,332
| -55% | -$949K | 0.08% | 149 |
|
|
2023
Q2 | $1.83M | Buy |
20,731
+1,630
| +9% | +$140K | 0.19% | 101 |
|
|
2023
Q1 | $1.54M | Buy |
19,101
+6,952
| +57% | +$567K | 0.17% | 111 |
|
|
2022
Q4 | $944K | Buy |
12,149
+928
| +8% | +$75.2K | 0.11% | 154 |
|
|
2022
Q3 | $906K | Buy |
11,221
+999
| +10% | +$89.8K | 0.12% | 132 |
|
|
2022
Q2 | $917K | Buy |
10,222
+635
| +7% | +$64.3K | 0.12% | 129 |
|
|
2022
Q1 | $1.06M | Buy |
9,587
+18
| +0.2% | +$1.9K | 0.12% | 129 |
|
|
2021
Q4 | $989K | Buy |
9,569
+792
| +9% | +$91.7K | 0.11% | 133 |
|
|
2021
Q3 | $1.1M | Sell |
8,777
-111
| -1% | -$14.4K | 0.14% | 119 |
|
|
2021
Q2 | $1.1M | Sell |
8,888
-921
| -9% | -$116K | 0.14% | 115 |
|
|
2021
Q1 | $1.16M | Sell |
9,809
-218
| -2% | -$25.6K | 0.17% | 104 |
|
|
2020
Q4 | $1.17M | Sell |
10,027
-920
| -8% | -$101K | 0.18% | 102 |
|
|
2020
Q3 | $1.14M | Buy |
10,947
+11
| +0.1% | +$1.1K | 0.19% | 104 |
|
|
2020
Q2 | $1M | Sell |
10,936
-370
| -3% | -$35.5K | 0.18% | 109 |
|
|
2020
Q1 | $1.02M | Buy |
11,306
+432
| +4% | +$46K | 0.2% | 99 |
|
|
2019
Q4 | $1.23M | Buy |
10,874
+1,463
| +16% | +$161K | 0.2% | 110 |
|
|
2019
Q3 | $1.02M | Buy |
9,411
+596
| +7% | +$62.2K | 0.19% | 107 |
|
|
2019
Q2 | $858K | Buy |
8,815
+852
| +11% | +$77.8K | 0.15% | 121 |
|
|
2019
Q1 | $725K | Buy |
7,963
+3,243
| +69% | +$290K | 0.14% | 130 |
|
|
2018
Q4 | $429K | Buy |
4,720
+1,758
| +59% | +$164K | 0.09% | 157 |
|
|
2018
Q3 | $291K | Buy |
2,962
+377
| +15% | +$34.9K | 0.05% | 205 |
|
|
2018
Q2 | $221K | Buy |
+2,585
| New | +$216K | 0.04% | 239 |
|
|
2018
Q1 | – | Sell |
-2,639
| Closed | -$213K | – | 278 |
|
|
2017
Q4 | $213K | Sell |
2,639
-64
| -2% | -$5.13K | 0.04% | 255 |
|
|
2017
Q3 | $210K | Sell |
2,703
-125
| -4% | -$10.4K | 0.04% | 240 |
|
|
2017
Q2 | $251K | Sell |
2,828
-87
| -3% | -$7.34K | 0.05% | 223 |
|
|
2017
Q1 | $235K | Sell |
2,915
-31
| -1% | -$2.42K | 0.06% | 211 |
|
|
2016
Q4 | $210K | Buy |
2,946
+314
| +12% | +$24.7K | 0.06% | 206 |
|
|
2016
Q3 | $227K | Buy |
2,632
+199
| +8% | +$17.3K | 0.08% | 185 |
|
|
2016
Q2 | $211K | Sell |
2,433
-250
| -9% | -$20.2K | 0.08% | 181 |
|
|
2016
Q1 | $201K | Buy |
2,683
+25
| +0.9% | +$1.88K | 0.09% | 176 |
|
|
2015
Q4 | $204K | Buy |
+2,658
| New | +$200K | 0.1% | 167 |
|
|
2015
Q3 | – | Sell |
-2,776
| Closed | -$206K | – | 160 |
|
|
2015
Q2 | $206K | Buy |
+2,776
| New | +$212K | 0.12% | 143 |
|
Other funds holding MDT
Girard Partners's MDT Position: Q2 2024 in Review
Girard Partners reduced its Medtronic (MDT) stake by 8.4% in Q2 2024, selling an estimated $32.9K and leaving 4,372 shares worth $344K. The position accounts for 0.03% of the portfolio, ranked #212.
Girard Partners first reported a position in MDT in Q2 2015 and has held it in 35 quarters since. The position peaked at $1.83M in Q2 2023. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.
- Girard Partners held 4,372 shares of Medtronic worth $344K as of Q2 2024.
- Girard Partners sold 401 Medtronic shares in Q2 2024, an estimated $32.9K.
- Medtronic made up 0.03% of Girard Partners's portfolio in Q2 2024, its #212 holding.
- Girard Partners first reported a position in Medtronic in Q2 2015 and has held it in 35 quarters since.
- Girard Partners's Medtronic position peaked at $1.83M in Q2 2023.
- 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.
Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.